Picture of Bioxytran logo

BIXT Bioxytran Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Bioxytran, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.318-0.296-1.86-2.54-4.53
Depreciation
Non-Cash Items0.2220.0781.311.180.66
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.060.0330.1210.2632.17
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-0.019-0.186-0.431-1.1-1.7
Capital Expenditures-0.01-0.037
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items00
Other Investing Cash Flow
Cash from Investing Activities00-0.01-0.037
Financing Cash Flow Items0.950.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.0230.2220.5640.9811.76
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0040.0360.133-0.1280.031

Or unlock with your email

Or unlock with your email